Guardian Biotechnologies
| Company type | Private |
|---|---|
| Industry | Plant biotechnology, Molecular farming (Plant-made pharmaceuticals) |
| Founded | August 2002 |
| Headquarters | Saskatoon, Saskatchewan, Canada |
Key people | Sun Lee (CEO), Jim MacPherson (R&D Director) |
| Products | Poultry vaccine for coccidiosis, Phase 2 trails (Canada) [1] |
| Parent | Nexgen Biotechnologies Inc., Korea |
| Website | http://www.guardianbio.com |
| Footnotes / references As on 27 October 2006 | |
Guardian Biotechnologies Inc. is a privately owned plant biotechnology company, founded in August 2002, that operates from its corporate headquarters in Saskatoon, Saskatchewan, Canada.
References
- ^ Fox, Jeffrey L (1 October 2006). "Turning plants into protein factories". Nature Biotechnology. 24 (10): 1191–1193. doi:10.1038/nbt1006-1191. PMID 17033647.
External links
- Official website
- Profile on NRC-Plant Biotechnology Institute's bulletin
 | This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it. |
 | This article about a Canadian corporation or company is a stub. You can help Wikipedia by expanding it. |
 | This Saskatchewan-related article is a stub. You can help Wikipedia by expanding it. |